Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for LENSAR, Inc. (LNSR : NSDQ)
 
 • Company Description   
LENSAR Inc. is a commercial-stage medical device company. It focuses on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. LENSAR Inc. is based in Orlando, Florida.

Number of Employees: 110

 
 • Price / Volume Information   
Yesterday's Closing Price: $7.13 Daily Weekly Monthly
20 Day Moving Average: 9,139 shares
Shares Outstanding: 10.98 (millions)
Market Capitalization: $78.32 (millions)
Beta: -0.20
52 Week High: $8.98
52 Week Low: $5.50
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -7.40% 1.05%
12 Week 20.85% 27.23%
Year To Date 19.03% 38.75%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2800 Discovery Drive
-
Orlando,FL 32826
USA
ph: 888-536-7271
fax: -
ir.contact@lensar.com http://www.lensar.com
 
 • General Corporate Information   
Officers
Nicholas T. Curtis - Chief Executive Officer and Director
William J. Link - Chairperson of the Board of Directors
Thomas R. Staab, II - Chief Financial Officer
Richard L. Lindstrom - Director
John P. McLaughlin - Director

Peer Information
LENSAR, Inc. (ABMD)
LENSAR, Inc. (DMDS)
LENSAR, Inc. (CPWY.)
LENSAR, Inc. (EQUR)
LENSAR, Inc. (ECIA)
LENSAR, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 52634L108
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 10.98
Most Recent Split Date: (:1)
Beta: -0.20
Market Capitalization: $78.32 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.68 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.46 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.57
Price/Cash Flow: -
Price / Sales: 2.13
EPS Growth
vs. Year Ago Period: -19.64%
vs. Previous Quarter: -63.41%
Sales Growth
vs. Year Ago Period: 32.61%
vs. Previous Quarter: -16.77%
ROE
03/31/22 - -37.77
12/31/21 - -32.96
09/30/21 - -36.01
ROA
03/31/22 - -31.56
12/31/21 - -27.94
09/30/21 - -30.73
Current Ratio
03/31/22 - 4.97
12/31/21 - 5.14
09/30/21 - 5.81
Quick Ratio
03/31/22 - 4.41
12/31/21 - 4.40
09/30/21 - 4.55
Operating Margin
03/31/22 - -57.39
12/31/21 - -56.88
09/30/21 - -71.47
Net Margin
03/31/22 - -57.39
12/31/21 - -56.88
09/30/21 - -71.47
Pre-Tax Margin
03/31/22 - -57.39
12/31/21 - -56.88
09/30/21 - -71.47
Book Value
03/31/22 - 4.53
12/31/21 - 5.01
09/30/21 - 5.21
Inventory Turnover
03/31/22 - 2.17
12/31/21 - 1.58
09/30/21 - 1.19
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©